Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
1 drugs in development
By Therapeutic Area
top 0
No TA breakdown available.
R&D Momentum
67/100
Pipeline Velocity
27/100
Trial Completion Rate
89/100
Pipeline Concentration
100/100
Pipeline Freshness
11/100
Activity
Last 14 days
Survey to Determine Incarcerated Persons Views on Surrogate Decision-Making
A Pilot Study of the Effect of Spironolactone Therapy on Exercise Capacity and Endothelial Dysfunction in Pulmonary Arterial Hypertension
Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use
A Natural History Study of Novel Biomarkers in Pulmonary Arterial Hypertension
Studies of Phlebotomy Therapy in Hereditary Hemochromatosis
A Rigid Body Database on Human Movement
Development and Evaluation of Techniques for Computer Aided Detection and Diagnosis From Existing Radiologic Images
Exploring a Dietary Behavior Intervention in African-Americans at Risk for Cardiovascular Disease: A Community Acceptability and Feasibility Study
A Prospective Study of Transfusion-Transmitted Infections
Vasti Control of Patellofemoral Kinematics in Asymptomatic Volunteers
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)